Adults 18 to 100, any sex, with Chronic Disease or Rheumatic Diseases. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Perceived Usefulness of the ApplicationPrimary· Within an hour after using the application
Study-specific questions on perceived usefulness of the application
It was meaningful and relevant to use the app
Group
Value
95% CI
Mobile Application
12
Mobile Application
0
Mobile Application
0
Mobile Application
0
I became more aware of my own strengths by using the app
Group
Value
95% CI
Mobile Application
9
Mobile Application
1
Mobile Application
2
Mobile Application
0
It was useful for me to see an overview of my own strengths
Group
Value
95% CI
Mobile Application
10
Mobile Application
0
Mobile Application
2
Mobile Application
0
It was useful for me to be able to register a goal
Group
Value
95% CI
Mobile Application
5
Mobile Application
2
Mobile Application
4
Mobile Application
1
It was useful for me to be able to link the strengths to concrete goals
Group
Value
95% CI
Mobile Application
6
Mobile Application
0
Mobile Application
5
Mobile Application
1
I liked the possibility to register my own notes
Group
Value
95% CI
Mobile Application
7
Mobile Application
0
Mobile Application
4
Mobile Application
1
For me it would be relevant to share the overview of my strengths with my healthcare provider
Group
Value
95% CI
Mobile Application
8
Mobile Application
0
Mobile Application
4
Mobile Application
0
It was boring to use the app
Group
Value
95% CI
Mobile Application
2
Mobile Application
9
Mobile Application
1
Mobile Application
0
The System Usability ScalePrimary· Within an hour after using the application
This 10 item questionnaire measures usability. Each item has 5 response options with total score ranging from 0 to 100. Higher values represent a better outcome.
Group
Value
95% CI
Mobile Application
86.3
70 – 100
The Positive and Negative Affect Schedule.Secondary· Pre-intervention and post-intervention, within an hour after using the application
This scale measures positive and negative affect with two subscales (positive affect and negative affect). Positive affect subscale scores can range from 10-50, with higher scores representing higher levels of positive affect. Negative affect subscale scores can range from 10-50, with lower scores representing lower levels of negative affect.
Positive emotion sub scale (pre-intervention)
Group
Value
95% CI
Mobile Application
34.0
31.0 – 46.0
Positive emotion sub scale (post-intervention)
Group
Value
95% CI
Mobile Application
35.0
28.0 – 45.0
Negative emotion subscale (pre-intervention)
Group
Value
95% CI
Mobile Application
12.0
10.0 – 23.0
Negative emotion (post-intervention)
Group
Value
95% CI
Mobile Application
11.0
10.0 – 16.0
The Arthritis Self-efficacy ScaleSecondary· Pre-intervention and post-intervention, within an hour after using the application
This scale measures self-efficacy with two subscales with 5 response options. The "pain" subscale has 5 items and a score range from 0 to 20. The "other symptoms" subscale has 6 items and a score range from 0 to 24. Higher scores equal higher levels of self-efficacy.
Pain sub scale (pre-intervention)
Group
Value
95% CI
Mobile Application
12.0
5.0 – 16.0
Pain sub scale (post-intervention)
Group
Value
95% CI
Mobile Application
14.0
6.0 – 17.0
Other symptoms sub scale (pre-intervention)
Group
Value
95% CI
Mobile Application
16.0
8.0 – 22.0
Other symptoms subscale (post-intervention)
Group
Value
95% CI
Mobile Application
17.0
10.0 – 22.0
Sponsor's own description
Self-management of chronic illness can be highly demanding and people need to mobilize their personal strengths in order to live well with their condition. A mobile application was designed in collaboration with people with chronic illness and health care providers with the aims to support awareness of patients' strengths and patient-provider dialogues that include strengths. The aim of the present study is to evaluate with mixed methods the perceived usefulness and usability of the application and potential effects of the application on patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07489261 — Effect of Mobile Application- and AI Supported Video-Based Patient Education on Patient Outcomes in Teaching Clean Inter
· NA
· not yet recruiting
NCT07371364 — Mobile Application for Women With Polycystic Ovary Syndrome
· NA
· active not recruiting
NCT06687538 — Effect of Education to be Provided to Patients to Undergo TURP With Mobile Application on Patient Outcomes
· NA
· recruiting
NCT07012070 — Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers
· NA
· recruiting
NCT06442774 — MamaConecta: Digital Tool for Maternal Mental Health
· NA
· recruiting
Other recruiting trials for Chronic Disease
Currently open trials in the same condition.
NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being
· NA
· recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life
· NA
· recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity
· NA
· recruiting
NCT07375550 — Determinants of Medication Non-Adherence Among Patients With Chronic Diseases in Egyptian Community Pharmacies
· recruiting
NCT07120464 — Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
· recruiting
Other Oslo University Hospital trials
Trials by the same sponsor.
NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure
· NA
· not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure
· not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R
· NA
· recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study
· recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients
· Phase 1
· withdrawn
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 16 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03437863.